These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1448243)

  • 21. HLA-A, -B and -DR antigen frequencies of the London Cord Blood Bank units differ from those found in established bone marrow donor registries.
    Brown J; Poles A; Brown CJ; Contreras M; Navarrete CV
    Bone Marrow Transplant; 2000 Mar; 25(5):475-81. PubMed ID: 10713622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of immunologic factors in the etiology of pregnancy-induced hypertension].
    Steck T; Würfel W
    Zentralbl Gynakol; 1995; 117(1):3-10. PubMed ID: 7879459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
    Beer AE; Semprini AE; Zhu XY; Quebbeman JF
    Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertensive disorders in normal/over-weight and obese type 2 diabetic pregnant women.
    Colatrella A; Braucci S; Festa C; Bianchi P; Fallucca F; Mattei L; Trappolini M; Napoli A
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):373-7. PubMed ID: 19536738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension.
    Florio P; Torricelli M; De Falco G; Leucci E; Giovannelli A; Gazzolo D; Severi FM; Bagnoli F; Leoncini L; Linton EA; Petraglia F
    J Hypertens; 2006 Sep; 24(9):1831-40. PubMed ID: 16915033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin G and complement C3 levels in pregnancy induced hypertension.
    Ramdenee GR; Matah M; Bhatia BD; Sen MR; Swain S
    Indian Pediatr; 1995 Feb; 32(2):179-83. PubMed ID: 8635779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of A, B, C and DR antigens in definite Meniere's disease in a Spanish population.
    López-Escámez JA; López-Nevot A; Cortes R; Ramal L; López-Nevot MA
    Eur Arch Otorhinolaryngol; 2002 Aug; 259(7):347-50. PubMed ID: 12189399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of pregnancy-induced hypertension on birthweight by gestational age.
    Xiong X; Fraser WD
    Paediatr Perinat Epidemiol; 2004 May; 18(3):186-91. PubMed ID: 15130157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal human leukocyte antigen-G polymorphism is not associated with pre-eclampsia in a Chinese Han population.
    Lin A; Yan WH; Dai MZ; Chen XJ; Li BL; Chen BG; Fan LA
    Tissue Antigens; 2006 Oct; 68(4):311-6. PubMed ID: 17026466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Egg donation pregnancy as an immunological model for solid organ transplantation.
    van der Hoorn ML; Scherjon SA; Claas FH
    Transpl Immunol; 2011 Sep; 25(2-3):89-95. PubMed ID: 21708252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA antigens-antibodies system and its association with severe toxemia of pregnancy.
    Fujisawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):124-30. PubMed ID: 3973430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced maternal anti-fetal immunity contributes to the severity of hypertensive disorder complicating pregnancy.
    Liu LP; Huang W; Lu YC; Liao AH
    Am J Reprod Immunol; 2010 May; 63(5):379-86. PubMed ID: 20070286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal effects of maternal-fetal HLA compatibility.
    Ober C; Simpson JL; Ward M; Radvany RM; Andersen R; Elias S; Sabbagha R
    Am J Reprod Immunol Microbiol; 1987 Dec; 15(4):141-9. PubMed ID: 3481221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal-fetal HLA sharing and risk of newborn encephalopathy and seizures: a pilot study.
    Cowan LD; Hudson L; Bobele G; Chancellor I; Baker J
    J Child Neurol; 1994 Apr; 9(2):173-7. PubMed ID: 8006370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal-Fetal HLA Compatibility in Uncomplicated and Preeclamptic Naturally Conceived Pregnancies.
    van 't Hof LJ; Schotvanger N; Haasnoot GW; van der Keur C; Roelen DL; Lashley LEELO; Claas FHJ; Eikmans M; van der Hoorn MP
    Front Immunol; 2021; 12():673131. PubMed ID: 34054856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some immunological aspects of preeclampsia.
    Need JA
    Perspect Nephrol Hypertens; 1976; 5():169-76. PubMed ID: 137384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reciprocal HLA-DR allogenicity between mother and child affects pregnancy outcome parameters.
    Craenmehr MHC; van Egmond A; Haasnoot GW; Eikmans M; Roelen DL; Heidt S; Scherjon SA; Claas FHJ
    J Reprod Immunol; 2019 Jun; 133():15-17. PubMed ID: 31071643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review.
    Saftlas AF; Beydoun H; Triche E
    Obstet Gynecol; 2005 Jul; 106(1):162-72. PubMed ID: 15994633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of maternal lymphocytotoxic antibodies with obstetric complications.
    Harris RE; Lordon RE
    Obstet Gynecol; 1976 Sep; 48(3):302-4. PubMed ID: 948375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.